Peanut Allergy Treatment Market Set to Grow on Rapid Adoption of 3D Printing

the Peanut Allergy Treatment Market is expected to grow by leaps and bounds over the forecast period. The medical application of nanotechnology is on the anvil. As such, nanomedicine is the result of technology operating at the molecular, atomic or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the health vertical constantly updated.

Peanut allergy is the most common childhood food allergy. About 2.5% of children suffered from peanut allergy in the United States. Peanut allergy can cause several allergic reactions, including anaphylaxis. There are no approved treatments available for peanut allergy, only experimental drugs are used for the treatment of peanut allergy.

But manufacturers and researchers are studying the use of immunotherapy drugs for the treatment of peanut allergy. Immunotherapy drugs are not FDA approved so far. The FDA is expected to approve one or more peanut allergy immunotherapy products for the treatment of peanut allergies.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/28831

Companies such as DBV Technologies, Aimmune Therapeutics, Prota Therapeutics Pty Ltd., Camallergy are conducting clinical trials for the development of peanut allergy treatment products. DBV Technologies’ Viaskin Peanut immunotherapy product is likely to be the first peanut allergy treatment product on the market. Viaskin Peanut is a skin or dermal patch containing 250 micrograms of peanut protein medicine.

The peanut allergy treatment market is expected to grow with a double-digit growth rate owing to the anticipated launch of the new products in the market. These products will be increasingly in demand in the market due to the unavailability of medications for the treatment of peanut allergies.

The peanut allergy treatment market is expected to witness a significant growth rate over the forecast period as an increasing number of clinics are visiting for allergy treatment. An increasing number of research and development for the launch of immunotherapy products is expected to boost the growth opportunities for the peanut allergy treatment market. The peanut allergy treatment market is going to grow over the forecast period with the increase in investments, scientific developments and commercial activities.

Request for [email protected] https://www.persistencemarketresearch.com/toc/28831

Market segmentation

Type of drug
  • Epinephrine injection (EpiPen, Twinject, AUVI-Q)
  • Antihistamines
Route of administration
Distribution channel
  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies
  • Pharmacy

Access Full Report @ https://www.persistencemarketresearch.com/checkout/28831

Regionally, the global peanut allergy treatment market is segmented into five key regions, viz. North America, Latin America, Europe, Middle East and Africa and Asia-Pacific. North America is expected to contribute a major share of the global peanut allergy treatment market revenue owing to the high prevalence of peanut allergy.

North America and Europe are expected to gain major share of the peanut allergy treatment market owing to the increasing prevalence of peanut allergy in western countries. The peanut allergy treatment market in Asia-Pacific region is expected to witness a significant growth rate in the coming years owing to the growing number of allergy tests and rising healthcare expenditures.

Some of the players operating in the global peanut allergy treatment market are Mylan Inc., Sanofi SA, Pfizer Inc., kaleo, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Inc., DBV Technologies, Aimmune Therapeutics, Prota Therapeutics Pty Ltd., and others.

Access related reports:

ISO certification market

Global ISO certification market – explore the share, size, revenue, valuation, CAGR, regional outlook, key players, competitive landscape, latest trends and forecast.

Patient Throughput and Capacity Management Market

PMR’s analysis of key trends, drivers, restraints and opportunities influencing the progress of the global economy patient throughput and capacity management market.

About Us: Persistence Market Research

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York,
NY 10007 USA
Telephone in the United States – +1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales[email protected]

Comments are closed.